Trials / Sponsors / AsclepiX Therapeutics, Inc.
AsclepiX Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD) Neovascular Age-related Macular Degeneration | Phase 1 / Phase 2 | 2023-12-19 |
| Terminated | Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration Neovascular Age-Related Macular Degeneration (nAMD) | Phase 1 / Phase 2 | 2021-02-01 |
| Terminated | Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema Diabetic Macular Edema (DME) | Phase 1 / Phase 2 | 2020-12-10 |